Attestation committee
Accreditation committee
Expert committee
Dispositions, instructions
Normative acts
Nomenclature
Institutions
Scientific councils
Seminars
Theses
Scientific advisers
Scientists
Doctoral students
Postdoctoral students
CNAA logo

 română | русский | english


Revenco Valeriu, doctor habilitat, professorRevenco Valeriu, doctor habilitat, professor


Institution:Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova
Adviser Number:18 June, 2009, nr.962
Specialties: 14.00.06 - Cardiology and Reumatology

Approved theses [10]

Dg Title Specialty Institution Role Approval date
D Corelațiile morfo-clinice ale ramurilor arterelor coronare și traiectului lor intramural 14.00.02 Nicolae Testemitanu State... adviser
adviser
Catereniuc Ilia
01.07.2022
D The impact of metabolic syndrome and its components on right chambers of the heart 14.00.06 Nicolae Testemitanu State... adviser 25.06.2021
D Intrarenal hemodynamics in arterial hypertension and dysglycemia – the connecting link between microvascular and macrovascular damage 14.00.06 Nicolae Testemitanu State... adviser 06.12.2019
D Clinical and paraclinical characteristics of cardiac autonomic neuropathy in type 1 diabetes mellitus 14.00.03 Nicolae Testemitanu State... consultant
adviser
Vudu Lorina
31.05.2017
D Aspects of clinical course and risk factors of arterial hypertension in children 14.00.09 Nicolae Testemitanu State... consultant
adviser
Rudi Marcu
09.10.2012
DH Metabolic Syndrome: Peculiarities of Etiopathogenesis 14.00.05 consultant 06.10.2010
D Clinical-hemodynamic and biochemical aspects to the patients with arterial hypertension and obesity and the influence of imidazolinic I1 receptors agonist - monoxidine 14.00.06 Nicolae Testemitanu State... adviser 03.06.2010
D Particularities of cardiovascular pathology in systemic lupus erythematosus 14.00.06 adviser 01.10.2009
D Prevalenţa cardiopatiei ischemice şi a unor factori de risc în populaţia din oraşul Taiz (Republica Yemen) 14.00.06 adviser 23.02.2006
D Clinical-hemodynamic and biochemical aspects at the patients with arterial hypertension and obesity and the influence of selective β-adrenoblocant Nebivolol 14.00.06 adviser 22.09.2005